Polycaprolactone-20% tricalcium phosphate scaffolds in combination with platelet-rich plasma for the treatment of critical-sized defects of the mandible: a pilot study.

PURPOSE Our group has recently fabricated 3-dimensional scaffolds of unique architecture to mediate favorable cell binding, proliferation, and differentiation. In this study, the osteoconductive and bioactive polycaprolactone-20% tricalcium phosphate (PCL-TCP) scaffolds were assessed for the treatment of critical-sized defects of the mandible, with respect to new bone formation. Platelet-rich plasma (PRP) was combined with some scaffolds to test if bone regeneration could be enhanced. MATERIALS AND METHODS Autologous PRP was prepared from whole blood collected from 8 mongrel dogs. In each dog, 3 defects (18 x 10 x 7 mm) were created at either the left or right mandible and treated with 1 of 2 treatment modalities: 1) grafting with scaffolds alone; or 2) grafting with scaffolds loaded with PRP. The scaffolds were stabilized using 2 dental implants each to prevent rotation. Micro-CT and histologic analysis were carried out on samples after 6 and 9 months. RESULTS Micro-CT measurements showed that PRP-treated defects had 98.3% and 58.3% more bone volume fraction than defects grafted with scaffolds alone at 6 and 9 months, respectively (P < .05). No significant difference was noted between caudal and frontal situated PRP-treated defects, but a significant difference was observed between male and female dogs. Histologic analyses verified the deposition of osteoid and new bone trabeculae throughout the section at 6 months. The defect margins were filled with mature bone trabeculae at 9 months but the middle section of the scaffolds manifested disturbed mineralization. The scaffolds experienced 33% degradation from 6 to 9 months. PRP treatment had negligible effect on the degradation of the scaffolds. CONCLUSIONS The pilot study showed that the treatment of critical-sized defects of the mandible with PCL-TCP scaffolds may be augmented by the addition of PRP.

[1]  R. Marx,et al.  Platelet-rich plasma: Growth factor enhancement for bone grafts. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[2]  M. Heberer,et al.  Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro , 2001, Journal of cellular biochemistry.

[3]  A. Vissink,et al.  Does platelet-rich plasma promote remodeling of autologous bone grafts used for augmentation of the maxillary sinus floor? , 2005, Clinical oral implants research.

[4]  F. Kloss,et al.  Effects of platelet-rich plasma on bone healing in combination with autogenous bone and bone substitutes in critical-size defects. An animal experiment. , 2004, Clinical oral implants research.

[5]  E. Freymiller,et al.  Platelet-rich plasma: ready or not? , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[6]  T. Kawase,et al.  Platelet-rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans: a comparative controlled clinical study. , 2005, Journal of periodontology.

[7]  K. Koyano,et al.  The effect of platelet-rich plasma on the cellular response of rat bone marrow cells in vitro. , 2005, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[8]  H. Liu,et al.  Re-expression of differentiated proteoglycan phenotype by dedifferentiated human chondrocytes during culture in alginate beads. , 1998, Biochimica et biophysica acta.

[9]  R. Haas,et al.  Influence of platelet-rich plasma on osseous healing of dental implants: a histologic and histomorphometric study in minipigs. , 2003, The International journal of oral & maxillofacial implants.

[10]  S. Teoh,et al.  An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[11]  M. Schimpf,et al.  Bioerodible polymers for delivery of macromolecules , 1990 .

[12]  T. Lim,et al.  Induction of Ectopic Bone Formation by Using Human Periosteal Cells in Combination with a Novel Scaffold Technology , 2002, Cell transplantation.

[13]  Subburaman Mohan,et al.  Growth factors for bone growth and repair: IGF, TGFβ and BMP , 1996 .

[14]  S. Teoh,et al.  Scaffold design and in vitro study of osteochondral coculture in a three-dimensional porous polycaprolactone scaffold fabricated by fused deposition modeling. , 2003, Tissue engineering.

[15]  R. Marx.  Platelet-rich plasma: evidence to support its use. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[16]  Masakazu Kawashita,et al.  Novel bioactive materials with different mechanical properties. , 2003, Biomaterials.

[17]  Young-Kyun Kim,et al.  Use of particulate dentin-plaster of Paris combination with/without platelet-rich plasma in the treatment of bone defects around implants. , 2002, The International journal of oral & maxillofacial implants.

[18]  Robert E Guldberg,et al.  Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair. , 2007, Journal of biomedical materials research. Part A.

[19]  J. Jansen,et al.  Reconstruction of the mandible with an autogenous irradiated cortical scaffold, autogenous corticocancellous bone-graft and autogenous platelet-rich-plasma: an animal experiment. , 2005, International journal of oral and maxillofacial surgery.

[20]  H. Schliephake.  Bone growth factors in maxillofacial skeletal reconstruction , 2002 .

[21]  T. Tözüm,et al.  Platelet-rich plasma: a promising innovation in dentistry. , 2003, Journal.

[22]  D W Hutmacher,et al.  The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds. , 2004, Biomaterials.

[23]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[24]  S. Teoh,et al.  In vitro degradation of novel bioactive polycaprolactone—20% tricalcium phosphate composite scaffolds for bone engineering , 2007 .

[25]  I. Zein,et al.  Fused deposition modeling of novel scaffold architectures for tissue engineering applications. , 2002, Biomaterials.

[26]  J. Huh,et al.  Effect of platelet-rich plasma on bone regeneration in autogenous bone graft. , 2004, International journal of oral and maxillofacial surgery.

[27]  A. Schindler,et al.  Aliphatic polyesters. I. The degradation of poly(ϵ‐caprolactone) in vivo , 1981 .

[28]  S. Feinberg,et al.  Role of tissue engineering in oral and maxillofacial reconstruction: findings of the 2005 AAOMS Research Summit. , 2005, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[29]  D. Hutmacher,et al.  Osteogenic induction of human bone marrow-derived mesenchymal progenitor cells in novel synthetic polymer-hydrogel matrices. , 2003, Tissue engineering.